MLchartDataset catalogue

Sodium phenylbutyrate

Term · Oncology and biomedicine · MLC-T-ONC-016806

The sodium salt of phenylbutyrate, a derivative of the short-chain fatty acid butyrate, with potential antineoplastic activity. Phenylbutyrate reversibly inhibits class I and II histone deacetylases (HDACs), which may result in a global increase in gene expression, decreased cellular proliferation, increased cell differentiation, and the induction of apoptosis in susceptible tumor cell populations.

Table 1. Record
IdentifierMLC-T-ONC-016806
FieldOncology and biomedicine
Synonymssodium 4-phenylbutyrate
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016806",
  "term": "Sodium phenylbutyrate",
  "field": "Oncology and biomedicine",
  "definition": "The sodium salt of phenylbutyrate, a derivative of the short-chain fatty acid butyrate, with potential antineoplastic activity. Phenylbutyrate reversibly inhibits class I and II histone deacetylases (HDACs), which may result in a global increase in gene expression, decreased cellular proliferation, increased cell differentiation, and the induction of apoptosis in susceptible tumor cell populations.",
  "synonyms": [
    "sodium 4-phenylbutyrate"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/sodium-phenylbutyrate/"
}

Record 15,143 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.